Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Oncolytics Biotech Submits Amendment To GOBLET To Initiate New Phase 1/2 Cohort Evaluating Pelareorep In Combination With Modified FOLFIRINOX With And Without Tecentriq

Author: Benzinga Newsdesk | March 05, 2024 08:10am

Posted In: ONCY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist